Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic dysfunction-associated steatohepatitis and moderate or advanced liver ...

Parenteral nutrition (PN) is lifesaving for patients with short bowel syndrome and other gastrointestinal disorders, however long-term use may lead to complications including hepatosteatosis and ...

Phillip Frost; Chairman of the Board, Chief Executive Officer; OPKO Health Inc Elias Zerhouni; President, Vice Chairman of the Board; OPKO Health Inc Good afternoon, and welcome to the OPKO Health ...

Nonalcoholic fatty liver disease (NAFLD ... in reducing the NAFLD-induced inflammation and improving cellular histology. Successful treatment will need to include genetic or molecular-level ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...

A previously published study using a high-fat diet-induced non-alcoholic fatty liver mouse model showed that green tea ... and Koji Arihiro from the Department of Anatomical Pathology at Hiroshima ...

Nonalcoholic fatty liver disease (NAFLD ... and focus on current discussions related to the specific lesions in the pathology of NASH, including the challenges of pediatric NASH and NASH-related ...

This new article publication from Acta Pharmaceutica Sinica B , discusses how diabetes-associated sleep fragmentation impairs liver and heart function via SIRT1-dependent epigenetic modulation of ...

1 Department of Medical Gastroenterology, Hvidovre Hospital, University of Copenhagen, Denmark 2 Department of Pathology, Hvidovre Hospital ... Sanne.Dam-LarsenDadlnet.dk Background and aims: Fatty ...